December 19, 2023
An investor in biopharmaceutical company Acadia Pharmaceuticals Inc. has filed a derivative shareholder suit against the company's brass in San Diego federal court alleging the executives misrepresented its chances of receiving regulatory approval for one of its drugs to be used to treat psychological disorders related to dementia.